Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab
- Status
- COMPLETED
- Phase
- PHASE1
NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)
- Status
- COMPLETED
- Phase
- PHASE2
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Human Leukocyte Antigen (HLA) Class I Haplotype Mismatched Natural Killer Cell Infusions
- Status
- COMPLETED
- Phase
- PHASE1
Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of KX2-391 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients
- Status
- COMPLETED
- Phase
- NA
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- N/A
Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment
- Status
- COMPLETED
- Phase
- PHASE1
SNX-5422 to Treat Solid Tumor Cancers and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1